$175.35
6.23%
NYSE, Oct 20, 04:04 pm EDT. Closed.
Why the stock moved Why the stock moved Beta
ISIN
US23918K1088
Symbol
DVA

DaVita HealthCare Partners Target price 2026 - Analyst rating & recommendation

DaVita HealthCare Partners Classifications & Recommendation

Buy
54%
Hold
38%
Sell
8%

DaVita HealthCare Partners Price Target

Target Price $224.40
Price $175.35
Potential
Number of Estimates 9
9 Analysts have issued a price target DaVita HealthCare Partners 2027 . The average DaVita HealthCare Partners target price is $224.40. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 13 analysts: 7 Analysts recommend DaVita HealthCare Partners to buy, 5 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the DaVita HealthCare Partners stock has an average upside potential 2027 of . Most analysts recommend the DaVita HealthCare Partners stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ ??? ???
??? ???
EBITDA Margin ??? ???
??? ???
Net Margin ??? ???
??? ???

11 Analysts have issued a sales forecast DaVita HealthCare Partners 2026 . The average DaVita HealthCare Partners sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2025 $13.6b 6.46%
2026
2027
2028
2029
2030
2031
2032
2033

10 Analysts have issued an DaVita HealthCare Partners EBITDA forecast 2026. The average DaVita HealthCare Partners EBITDA estimate is

. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $2.7b 1.76%
2026
2027
2028
2029
2030
2031
2032
2033

EBITDA Margin

2025 19.98% 4.41%
2026
2027
2028
2029
2030
2031
2032
2033

11 DaVita HealthCare Partners Analysts have issued a net profit forecast 2026. The average DaVita HealthCare Partners net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $747m 20.24%
2026
2027
2028
2029
2030
2031
2032
2033

Net Margin

2025 5.47% 25.08%
2026
2027
2028
2029
2030
2031
2032
2033

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ ??? ???
??? ???
P/E ???
EV/Sales ???

11 Analysts have issued a DaVita HealthCare Partners forecast for earnings per share. The average DaVita HealthCare Partners EPS is

. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $9.84 8.29%
2026
2027
2028
2029
2030
2031
2032
2033

P/E ratio

Current 14.59 25.15%
2026
2027
2028
2029
2030
2031
2032
2033

Based on analysts' sales estimates for 2026, the DaVita HealthCare Partners stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.57 11.35%
2026
2027
2028
2029
2030
2031
2032
2033

P/S ratio

Current 0.85 24.52%
2026
2027
2028
2029
2030
2031
2032
2033

Current DaVita HealthCare Partners Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
Analyst Rating Date
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today